Trim 30% of AMAT exposure at $424 with hard stop at $405
UNDERWEIGHT — Trim 30% of AMAT position. The risk/reward at $424 is asymmetrically skewed: thin $13 cushion above the 200-SMA, hostile macro regime, contemporaneous earnings quality deterioration (10% QoQ net income decline despite record revenue), and working capital divergence with receivables growing at 2x revenue. The trim magnitude (30%) is calibrated to the upper end of the conviction range—enough de-risking to capture meaningful downside protection without abandoning a real secular thesis ahead of a binary Q4 earnings catalyst and an untested structural floor. Hard protective stop at $405 on retained core replaces the trader's structurally broken $485 stop.
| Position | Action |
|---|---|
| Current position | Trim 30% of existing AMAT exposure |
| Tranche 1 execution (50% of trim) | Limit sell at $435-445 (current resistance zone) |
| Tranche 2 execution (50% of trim) | Limit sell at $470-480 only on relief rally toward Bollinger mid/declining 10-EMA |
| Retained core position | 50-60% of original position sized to ~1.0x ATR (~$21) risk from $424 baseline |
| Hedge recommendation | Buy Dec $400-420 puts for ~5% downside protection at $8-12 cost per contract |
AMAT's 41% drawdown is a macro-driven sentiment shock, not a fundamental deterioration—the company has record revenue, expanding order books stretching "years into the future" per the CEO, elite 41% ROE and 33.7% operating margin, fortress balance sheet with $1.88B net cash, and trades at a sub-1 PEG ratio of 0.91 with 22.8x forward P/E.
| Indicator | Value | Signal |
|---|---|---|
| Close | $456.49 | neutral |
| 10-EMA | $461.47 | bearish |
| 50-SMA | $516.46 | bearish |
| 200-SMA | $411.04 | bullish |
| MACD Line | -18.21 | neutral |
| MACD Signal | -19.26 | neutral |
| MACD Histogram | +1.05 (positive crossover) | bullish |
| RSI | 41.71 | neutral |
| Bollinger Middle Band | $475.44 | neutral |
| Bollinger Lower Band | $422.95 | neutral |
| ATR | $21.39 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $475 reclaim on expanding weekly volume
Then: Pause trimming; reassess whether to add back or hold steady
· concedes: Chart is ugly and macro is hostile; 41% drawdown is real; High beta (1.6) means elevated volatility; Price is below 10-EMA ($461), 50-SMA ($516), and Bollinger mid ($475) in the short term; China export controls are a legitimate structural headwind; TTM P/E is 36x, presenting some multiple compression risk; Bear's technical indicators are correct in describing the short-term trend
AMAT is a cyclical peak trap dressed up as a quality compounder — forward EPS estimates are peak-cycle assumptions that will be revised down, inventory and receivables signal late-cycle behavior, the chart has already broken key technical levels, and the macro regime has shifted to stagflationary conditions that historically crush high-beta cyclicals.
EV: -$200 to -$180 per share (from current ~$424 to $240-260 range in recession scenario) · concedes: AMAT's 30% normalized ROE is still good, not elite; Q3 FY26 revenue was indeed a record ($9.12B); AMAT is buying back stock (though mechanically, not as a timing signal); Management buybacks at $424 vs $739 are objectively more dilutive to cost; Cramer endorsement being neutral information, not bearish
→ vs conservative: Trim at $456 while own 200-SMA stop at $411 has not fired is selling based on narrative rather than stated discipline — capitulation masquerading as risk management
→ vs conservative: Working capital increases reflect structural demand and multi-year order book visibility, not late-cycle channel stuffing like 2018-2019
→ vs conservative: Macro headwinds are already discounted in 38% drawdown; selling after the fact is backward-looking consensus strategy that is usually wrong at support levels
→ vs conservative: 25-30% trim at $456 crystallizes losses at the bottom and guarantees missing the next leg up; you cannot make money on a stock you don't own
→ vs neutral: Even if forward EPS $18.45 gets revised down 30% to $12.90, relative outperformance thesis holds as macro would have crushed all semiconductor names equally
→ vs neutral: At $424 current price, $740 target represents 75% upside; prior consolidation at $565 is only $109 away (24% rally)
| bullish |
Support: 435.86 · 422.95 · 411.04 · 396 | Resistance: 461.47 · 475 · 475.44 · 516.46
AMAT (Applied Materials, Inc.) shows a mixed technical picture as of 2026-09-11: bearish short-term (price $4.98 below 10-EMA) and medium-term (price $59.97 below 50-SMA), but bullish long-term (price $45.45 above 200-SMA). Key inflection at $475 (Bollinger mid) must be reclaimed for reversal confirmation; critical support at $411.04 (200-SMA) represents the long-term bull/bear line. Early reversal signals include a bullish MACD histogram crossover (+1.05), ATR contraction from $43.8 to $21.4, and emerging positive divergences. Recommended action: initiate starter long with stop below $405, target $516 (50-SMA), but do not add aggressively until $475 is reclaimed on a closing basis.
Market Cap
$334.24B
Share Price (implied)
~$420
Beta
1.60
52-Week High
$739.67
52-Week Low
$171.58
50-Day Moving Average
$513.28
200-Day Moving Average
$412.77
P/E Ratio (TTM)
36.37
Forward P/E
22.82
PEG Ratio
0.91
Price to Book
13.04
Dividend Yield
0.50%
EPS (TTM)
$11.58
Forward EPS
$18.45
TTM Revenue
$30.84B
Gross Margin (TTM)
49.4%
EBITDA Margin
32.9%
Operating Margin
33.7%
Profit Margin
30.1%
ROE
41.1%
ROA
15.5%
Q3 FY26 Revenue
$9.12B
Q1 FY26 Revenue
$7.01B
Q2 FY26 Revenue
$7.91B
Q3 FY26 Net Income
$2.54B
Q3 FY26 Operating Income
$3.08B
Q3 FY26 Diluted EPS
$3.17
Q1 FY26 Diluted EPS
$2.54
Q2 FY26 Diluted EPS
$3.51
FY21 Revenue
$25.78B
FY22 Revenue
$25.79B
FY23 Revenue
$26.52B
FY24 Revenue
$27.18B
FY25 Revenue
$28.37B
FY21 Diluted EPS
$7.44
FY22 Diluted EPS
$8.11
FY23 Diluted EPS
$8.11
FY24 Diluted EPS
$8.61
FY25 Diluted EPS
$8.66
FY25 Restructuring/Special Charges
$181M
Q3 FY26 R&D Spend
$1.10B
Total Assets
$43.52B
Total Liabilities
$17.90B
Total Equity
$25.63B
Long-Term Debt
$5.25B
Current Debt
$1.30B
Total Debt
$7.35B
Cash & ST Investments
$9.23B
Net Debt
($1.88B)
Current Ratio
2.42
Inventory
$6.56B
Receivables
$8.03B
PP&E (net)
$6.42B
Goodwill
$3.87B
Debt/Equity
0.287
Treasury Stock (cumulative)
$46.18B
Retained Earnings
$61.39B
Q3 FY26 Operating Cash Flow
$3.04B
Q2 FY26 Operating Cash Flow
$0.85B
Q3 FY26 CapEx
($0.71B)
Q3 FY26 Free Cash Flow
$2.33B
Q3 FY26 Buybacks
($0.44B)
Q3 FY26 Dividends
($0.42B)
FY21 OCF
$5.40B
FY22 OCF
$8.70B
FY23 OCF
$8.68B
FY24 OCF
$7.96B
FY21 CapEx
($0.79B)
FY22 CapEx
($1.11B)
FY23 CapEx
($1.19B)
FY24 CapEx
($2.26B)
FY21 FCF
$4.61B
FY22 FCF
$7.59B
FY23 FCF
$7.49B
FY24 FCF
$5.70B
TTM FCF
$3.08B
FY26 YTD Buybacks
~$4.4B
Annualized Dividend
~$1.7B
Quarterly Dividend FY26 Q3
$0.42
Total Shareholder Yield
~1.9%
China Revenue Exposure
~25-30%
Basic Shares Outstanding
~793.6M
Q3 FY26 Net Interest Expense
$168M
Gross PP&E
$10.61B
Construction-in-Progress
$2.04B
Strengths
Concerns
AMAT is a high-quality semiconductor equipment leader with record Q3 FY26 revenue of $9.12B and best-in-class profitability (41.1% ROE, 33.7% operating margin). The company sits at the center of the AI-driven wafer fab equipment super-cycle with fortress-grade financials ($1.88B net cash position). Forward EPS growth of ~59% ($11.58 TTM to $18.45) with a PEG ratio of 0.91 suggests the valuation is attractive relative to growth prospects. Principal risks include China export control headwinds potentially impacting 25-30% of revenue, inherent WFE cyclicality, high beta of 1.60, and working capital build (inventory and receivables) that warrants monitoring for cycle peak signals.
Macro: 10Y U.S. Treasury yield briefly topped 5%, reaching its highest level since 2007. WTI crude pushed back above $100/bbl (~$105). Polymarket prices 94% probability of zero Fed rate cuts in 2026 (volume ~$8.3M) and US recession by end-2026 at 16% (+9 percentage points in the past week — fastest re-pricing in the recent window). The combination pushed the Dow, S&P 500, and Nasdaq lower across multiple sessions, with high-multiple tech most exposed. AI capex sentiment also hit by rare cross-lab unity: Anthropic CEO Dario Amodei essay + OpenAI/SpaceX CEOs publicly aligned on calling for a slowdown in frontier AI development.